Sign in / Join Now
ETFs & Funds
Swedish Orphan Biovitrum AB
Sobi and Horizon Pharma inks deal for Ravicti and Ammonaps in Europe and Middle East
Yesterday, 8:13 AM
Roche's hemophilia candidate emicizumab shows encouraging results in early-stage study
Thu, Jul. 28
Biogen's Little Swedish Orphan Named Sobi
Wed, Jun. 29
Swedish Orphan's hemophilia A treatment approved in Switzerland
Mon, Jun. 27
Sobi and Biogen's Alprolix approved in Europe for hemophilia B
Fri, May 13
European Ad Comm gives thumbs up to Biogen/Sobi hemophilia A treatment
Sep. 25, 2015
EMA accepts Biogen and Sobi's MAA for Alprolix
Jun. 26, 2015
Biogen Idec (BIIB -1.8%) and Swedish Orphan Biovitrum (BIOVF.PK) present positive new data from...
Jul. 16, 2013
Biogen Idec (BIIB -0.7%) and Swedish Orphan Biovitrum AB (BIOVF.PK) present new findings for...
Jul. 2, 2013
Biogen IDEC (BIIB) and partner Swedish Orphan Biovitrum (BIOVF.PK) see positive top-line results...
Sep. 26, 2012